日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

​Did a Non-Medical Biosimilar Switching Policy Cause an Increase in Non-Biologic/Biosimilar Health Care Resource Utilization or Cost in Patients With Inflammatory Arthritis?

非医疗原因的生物类似药转换政策是否导致炎症性关节炎患者非生物制剂/生物类似药医疗资源利用率或成本增加?

Dang, HaoHung; Blitz, Sandra; Bansback, Nick; Law, Michael; Harrison, Mark

What do HTA agencies need for generating health-related quality of life evidence? Findings from a global survey

卫生技术评估机构需要哪些信息来生成与健康相关的生活质量证据?一项全球调查的结果

Vasan Thakumar, Annushiah; Lorgelly, Paula; Longworth, Louise; Rey-Ares, Lucila; Purba, Fredrick; Golicki, Dominik; Augustovski, Federico; Rand, Kim; Viney, Rosalie; Bansback, Nick; Luo, Nan

Continuous positive airway pressure and mandibular advancement splints: the CHOICE multicentre, open-label randomised clinical trial

持续气道正压通气和下颌前移矫治器:CHOICE 多中心、开放标签随机临床试验

Hamoda, Mona M; Huynh, Nelly; Ayas, Najib T; Rompré, Pierre; Bansback, Nick; Masse, Jean-François; Arcache, Patrick; Lavigne, Gilles; Series, Frederic; Fleetham, John A; Almeida, Fernanda R

Oral and injectable opioid agonist treatments for people who use street opioids: a systematic literature review and network meta-analysis

口服和注射用阿片类激动剂治疗街头阿片类药物使用者:系统文献综述和网络荟萃分析

Bansback, Nick; Tam, Alexander C T; Palis, Heather; Kanters, Steve; Popoff, Evan; Schechter, Martin T; Anis, Aslam H; Marsh, David C; Oviedo-Joekes, Eugenia

Patient Perceptions of Medication Therapy for Prevention of Posttraumatic Osteoarthritis Following Anterior Cruciate Ligament Injury: A Qualitative Content Analysis

患者对前交叉韧带损伤后创伤性骨关节炎预防药物治疗的认知:一项定性内容分析

Waddell, Lily M; Mitchener, Donald P; Frier, Kelly C; Jones, Morgan H; Losina, Elena; Bansback, Nick; Fraenkel, Liana; Kim, Jason S; Katz, Jeffrey N; Selzer, Faith; Easterbrook, Adam

Drivers of infliximab biosimilar uptake: A comparative analysis of new biosimilar initiations versus switching in a national rheumatology registry

英夫利昔单抗生物类似药应用驱动因素:一项基于国家风湿病注册登记的生物类似药新启动与转换的比较分析

Roberts, Eric Thomas; Bansback, Nick; Tseng, Chien-Wen; Shiboski, Stephen; Li, Jing; Schmajuk, Gabriela; Yazdany, Jinoos

Identifying characteristics for a cost-effective psoriatic arthritis biomarker test: a development-focused health technology assessment

确定经济有效的银屑病关节炎生物标志物检测的特征:一项以研发为导向的卫生技术评估

Tam, Alexander C T; Chandran, Vinod; Gladman, Dafna; Kulasingam, Vathany; Spackman, Eldon; Bansback, Nick

Patient preferences for drug therapy in inflammatory arthritis: protocol for a living systematic review and evidence map to inform clinical practice guidelines

炎症性关节炎患者药物治疗偏好:一项动态系统评价和证据图谱方案,旨在为临床实践指南提供依据

Saadat, Pakeezah; Bansback, Nick; Falahee, Marie; Hiligsmann, Mickaël; Tugwell, Peter; Buchbinder, Rachelle; Whittle, Samuel; Richards, Dawn P; Proulx, Laurie; Schunemann, Holger; Alonso-Coello, Pablo; Nieuwlaat, Robby; Wiercioch, Wojtek; Kuper, Simon; Pardo Pardo, Jordi; Hazlewood, Glen

Global disparities in access to hepatitis C medicines before and during the early phase of the COVID-19 pandemic: an ARIMA-based interrupted time series analysis

COVID-19 大流行初期及之前全球丙型肝炎药物可及性差异:基于 ARIMA 中断时间序列分析

Nisingizwe, Marie Paul; Tadrous, Mina; Janjua, Naveed Z; Bansback, Nick; Hedt-Gauthier, Bethany; Suda, Katie J; Law, Michael R

Active remote monitoring of long-term conditions with mobile devices: a systematic review of cost-effectiveness analyses

利用移动设备对长期疾病进行主动远程监测:成本效益分析的系统评价

Gavan, Sean P; Payne, Katherine; Dixon, William G; van der Veer, Sabine N; Tam, Alexander C T; Bansback, Nick